Press Releases

2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

2014
Dec 2014 | Download as pdf

St. Cloud Surgical Center is First ASC in U.S. to Utilize Xenex Germ-Zapping Robot to Disinfect Operating Rooms & Enhance Patient Safety more

Dec 2014 | Download as pdf

4 cheap small cap stocks I’ve got my eye for Christmas more

Dec 2014 | Download as pdf

Southern Biologics Network Established to Create Biologics Faster and Less Expensively more

Dec 2014 | Download as pdf

Morningside Ministries at the Manor is the First Skilled Nursing Facility in Texas to Protect Residents with Xenex Germ-Zapping Robot more

Dec 2014 | Download as pdf

RBA to cut rates in 2015: Still want to invest in term deposits? more

Nov 2014 | Download as pdf

Can robots help stop the Ebola outbreak? more

Nov 2014 | Download as pdf

Robots Help Fight Ebola more

Nov 2014 | Download as pdf

South Florida Hospital Unveils Ebola-Zapping Robot more

Nov 2014 | Download as pdf

Sonoma Valley Hospital uses robot to kill germs more

Nov 2014 | Download as pdf

Robots go to war against Ebola more

Nov 2014 | Download as pdf

New iTraumaCare CEO to pursue big growth more

Nov 2014 | Download as pdf

UAB and SRI have plans to spinoff more success more

Nov 2014 | Download as pdf

Launch of Galderma's new acne products more

Nov 2014 | Download as pdf

iTraumaCare’s new CEO to help company secure new funding more

Oct 2014 | Download as pdf

U.S. Air Force Hospital Langley Adds Xenex Ebola-Zapping Robot to Inventory more

Oct 2014 | Download as pdf

Forthcoming Acne Treatment Made With Exclusive (And Sustainable) East Indian Sandalwood Oil more

Oct 2014 | Download as pdf

Sonoma Valley Hospital Acquires Xenex Germ-Killing Robot to Enhance Patient Safety more

Oct 2014 | Download as pdf

Robot fights germs at Sharp Chula Vista Medical Center more

Oct 2014 | Download as pdf

Xenex updates protocols for germ-zapping robots in response to Ebola threat more

Oct 2014 | Download as pdf

How do we get rid of the endotoxins? Birmingham's  has the solution more

Oct 2014 | Download as pdf

Medical Device ® Positions New Leader for Next-Level Growth more

Oct 2014 |

The Xenex robot at South Shore Hospital featured on an Xploration Earth more

Oct 2014 | Download as pdf

Germ-zapping robot Gigi sets its sights on Ebola more

Oct 2014 | Download as pdf

Morningside Ventures leads a Series B round for DNAtrix more

Oct 2014 | Download as pdf

StemBioSys secures new research space at BioBridge Global more

Oct 2014 | Download as pdf

Birmingham's Soluble Therapeutics acquires Seattle company Dilyx Biotechnology more

Oct 2014 | Download as pdf

Company invents germ-zapping robot more

Sept 2014 | Download as pdf

Xenex Congratulates Houston Cancer Hospital more

Sept 2014 | Download as pdf

Australian grown Indian Sandalwood timber attracts lucrative Asian markets more

Sept 2014 | Download as pdf

DNATRIX ANNOUNCES TREATMENT OF FIRST PATIENT WITH DNX-2401 more

Sept 2014 | Download as pdf

Targeted Technology raises more than $40 million more

Sept 2014 | Download as pdf

Reducing Healthcare Associated Infections (HAIs): Not All UV Light is the Same more

Sept 2014 | Download as pdf

Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO more

Aug 2014 | Download as pdf

Three Birmingham companies recognized in PwC report more

Aug 2014 | Download as pdf

Former Kinetic Concepts Inc. CEO to lead StemBioSys

San Antonio-based biomedical company StemBioSys Inc. has tapped Catherine Burzik to serve as chairman of the company’s board of directors.

Burzik previously served as president, CEO and director Kinetic Concepts Inc., a medical device and regenerative medicine company that is also based in San Antonio. She has been an advisor to StemBioSys since early 2012 and is currently a general partner in Targeted Technology, an early stage venture capital firm concentrating on medical device, life sciences and biotech investments. Burzik succeeds StemBioSys founder Dr. Steven A. Davis.

In a separate move, StemBioSys has named Robert Hutchens as its new CEO. He is replacing Peter Savas as CEO, who left the company earlier this year to return to Boston. John W. Feik had served as interim CEO since May.

Hutchens comes to StemBioSys from New York, where he spent the last 11 years as a partner with international consulting firm Booz & Company. Hutchens played a key role with the firm’s health care practice, both in the U.S. and Europe, working with pharmaceutical and medical device manufacturers. He was also engaged in projects with the Centers for Disease Control and with a number of bio-terrorism defense efforts.

Davis and Feik will both remain with StemBioSys in director roles.

“It is a real coup for us, as a young company, to be able to secure Cathy Burzik and Bob Hutchens for these two key positions,” Davis explains. “They bring extraordinary leadership and industry experience to StemBioSys at this critical stage of our development. Their involvement speaks volumes about the confidence they have in the potential of the company’s patented and proprietary stem cell technology platforms.”

Says Burzik, “StemBioSys has very promising proprietary life science products which will accelerate research and therapy development in the rapidly growing field of stem cell-based regenerative medicine. Dr. Davis saw that potential early-on and built the company around that science and technology.”

San Antonio-based Targeted Technologies was the lead investor in StemBioSys’ recent Series A funding round.

“Our early-stage venture fund, Targeted Technologies, is highly encouraged with the progress that StemBioSys is making in both research and product development,” Burzik adds. “We look forward to product commercialization within the next year.”

Hutchens says there is “no question that StemBioSys can achieve a leadership role” in the stem cell research and regenerative medicine arenas.

Source: http://www.bizjournals.com/sanantonio/blog/2014/08/former-kinetic-concepts-inc-ceo-to-lead-stembiosys.html?page=all  back

Aug 2014 | Download as pdf

International dermatology company Galderma confirmed more

Aug 2014 | Download as pdf

AUSTRALIAN Sandalwood producer TFS Corporation will supply oil more

Aug 2014 | Download as pdf

San Antonio luring biotech firms with venture capital more

July 2014 | Download as pdf

Biotech firm secures nearly $5 million in funding, is relocating to San Antonio more

July 2014 | Download as pdf

Birmingham is on the front lines of medical research: take a look at this incredible biotech startup more

July 2014 | Download as pdf

Germ-Zapping Robots Fight C. diff and MRSA at Mercy Health Saint Mary's more

July 2014 | Download as pdf

Milford hospital enlists robots in war against infections more

July 2014 | Download as pdf

Xenex Testifies About UV Room Disinfection Technology Effectiveness to U.S. House of Representatives more

July 2014 | Download as pdf

Western Pa. hospitals test robot using ultraviolet rays to kill bacteria more

July 2014 | Download as pdf

Xenex Demonstrates UV Room Cleaning System’s Effectiveness in Reducing Hospital Acquired Infections more

July 2014 | Download as pdf

TFS flags record full-year profit more

June 2014 | Download as pdf

Sweet scented sandalwood flavour of month more

June 2014 | Download as pdf

House committee looks for new technology in Veterans Affairs hospitals more

June 2014 | Download as pdf

FDA grants fast track status to drug DNX-2401 for recurrent Glioblastoma more

May 2014 | Download as pdf

CEO shakeup at San Antonio biotech company StemBioSys more

May 2014 | Download as pdf

First harvest to be completed in June more

Mar 2014 | Download as pdf

BiO2 Medical Enrolls Subjects in the New U.S. FDA Early Feasibility Pilot Study for the Angel® Catheter more

Mar 2014 | Download as pdf

San Antonio biotech firm readies skin treatment for distribution more

Mar 2014 | Download as pdf

ViroXis Gets Approval To Initiate FDA Phase 2 Study For Molluscum Contagiosum more

Mar 2014 | Download as pdf

Medical technologies conference announces speaker lineup more

Mar 2014 | Download as pdf

Australian sandalwood sells for millions more

Mar 2014 | Download as pdf

Sandalwood exports as good as gold more

Feb 2014 | Download as pdf

Santalis Pharmaceuticals Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize OTC Dermatology Products more

Feb 2014 | Download as pdf

ViroXis Corporation Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize an OTC Dermatology Product more

Feb 2014 | Download as pdf

DNAtrix Awarded $10.8 Million Grant by the Cancer Prevention and Research Institute of Texas more

Feb 2014 | Download as pdf

ViroXis Corporation Achieves Key Clinical Milestones more

Jan 2014 | Download as pdf

There are growing concerns about the threat of an antibiotic crisis caused by the spread of drug-resistant superbugs. Those concerns could result in more